Biotech Values

[mcbio]

Re: MNTA BAX/FoB deal CC

Just took a listen. Thought it interesting around about the 9:30 mark or so where, in discussing the cost-profit share option on FoBs 3-6, I believe Wheeler guided for the earliest timeline for the IND for the third FoB being 2014.

Also thought it interesting the one caller who asked about if MNTA didn't get the cost-profit share option on the first two FoBs due to BAX already having done work on these FoBs. I kind of got the impression that Wheeler was talking around that a bit so maybe that is the reason MNTA didn't get the cost-profit share option on those first two FoBs. Could well be wrong. If that is the case, though, given the potential that some degree of work has already been performed on these first two FoBs, hopefully that will translate into a shortened timeline on the first two FoBs (presumably the possibility of an IND before 2014 given that was the earliest guidance for an IND on the third FoB).